CR-106

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCR-106
Drug Alias Namemacrophage inhibitory antibody (CuraGen/Abgenix)CR-106
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMacrophages inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuraGen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraGen Corp
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A